ContraFect Corp.
(NASDAQ : CFRX)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.14%149.280.0%$2657.27m
BNGOBioNano Genomics, Inc. -5.80%10.400.0%$2144.92m
GILDGilead Sciences, Inc. -1.02%64.811.0%$642.28m
AMGNAmgen, Inc. -0.40%250.051.3%$587.09m
REGNRegeneron Pharmaceuticals, Inc. 0.90%520.222.7%$494.85m
ILMNIllumina, Inc. -0.92%428.093.5%$487.75m
ALXNAlexion Pharmaceuticals, Inc. -0.42%155.032.0%$464.00m
CRSPCRISPR Therapeutics AG -1.80%161.000.6%$428.96m
NVAXNovavax, Inc. -2.42%128.0092.9%$404.60m
VRTXVertex Pharmaceuticals, Inc. -0.70%223.671.9%$375.62m
SRPTSarepta Therapeutics, Inc. -4.59%86.3413.8%$325.18m
BIIBBiogen, Inc. -0.23%264.551.7%$313.63m
SRNESorrento Therapeutics, Inc. -6.76%14.201.4%$312.00m
BNTXBioNTech SE -0.08%105.890.0%$293.31m
EXASEXACT Sciences Corp. 0.00%136.8519.6%$253.85m

Company Profile

ContraFect Corp. is a clinical stage biotechnology company, which engages in discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases. Its pipeline consists of CF-301, a bacteriophage-derived lysin with potent activity against Staphylococcus aureus bloodstream infections; and CF-404, which composed of three fully human monoclonal antibodies designed to treat all seasonal strains of human influenza. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.